Trial intelligence / Profile preview

Levodopa for Learning and Memory in Dyslexia and Healthy Subjects

NCT00111371Phase 4Unknown

Sponsor
Universitätsklinikum Münster
Start
Jan 2005
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of levodopa in dyslexia, sponsored by Universitätsklinikum Münster. Status: unknown.

02

Drugs

levodopa
03

Conditions

dyslexia

Beyond the preview

Go deeper on NCT00111371.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00111371.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call